The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Uspenskiy Yu.P.

Saint Petersburg State Pediatric Medical University;
Pavlov First Saint Petersburg State Medical University

Baryshnikova N.V.

Saint Petersburg State Pediatric Medical University;
Pavlov First Saint Petersburg State Medical University;
Institute of Experimental Medicine

Fominykh Yu.A.

Saint Petersburg State Pediatric Medical University

Shekhtman A.V.

Saint Elizabeth City Hospital

Efficacy of alpha-glutamyl-tryptophan in the treatment of chronic atrophic gastritis: case series

Authors:

Uspenskiy Yu.P., Baryshnikova N.V., Fominykh Yu.A., Shekhtman A.V.

More about the authors

Journal: Russian Journal of Evidence-Based Gastroenterology. 2024;13(4): 121‑128

DOI: 10.17116/dokgastro202413041121

Read: 4636 times

Download PDF (RU)
Contact the author
Table of contents

EFFICACY OF ALPHA-GLUTAMYL-TRYPTOPHAN IN THE TREATMENT OF CHRONIC ATROPHIC GASTRITIS: CASE SERIES
EFFICACY OF ALPHA-GLUTAMYL-TRYPTOPHAN IN THE TREATMENT OF CHRONIC ATROPHIC GASTRITIS: CASE SERIES

To cite this article:

Uspenskiy YuP, Baryshnikova NV, Fominykh YuA, Shekhtman AV. Efficacy of alpha-glutamyl-tryptophan in the treatment of chronic atrophic gastritis: case series. Russian Journal of Evidence-Based Gastroenterology. 2024;13(4):121‑128. (In Russ.)
https://doi.org/10.17116/dokgastro202413041121

Подписка 2026 Доказательная гастроэнтерология (Russian Journal of Evidence-Based Gastroenterology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Evaluating the effi­cacy of the Kyoto classification of gastritis in diagnosing Heli­cobacter pylori infe­ction. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):29-38
Use of alpha-glutamyl-tryptophan in patients with chro­nic atro­phic autoimmune gastritis: inte­rim study resu­lts. Russian Journal of Evidence-Based Gastroenterology. 2025;(2):5-11
The level of hypo­xia-induced factor-1a and asso­ciated mole­cules in preeclampsia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):5-10
Asse­ssment of olfa­ctory level in acute sinu­sitis. Russian Rhinology. 2025;(1):6-11
Stru­ctural and functional tissue response to implants in patients with recu­rrent abdo­minal wall hernias in long-term period. Piro­gov Russian Journal of Surgery. 2025;(4):39-45
Therapeutic pote­ntial of quercetin and its deri­vatives against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(5):44-50
Expe­rimental and clinical evaluation of the safety and effi­cacy of Poly­dexa spray with phenylephrine in acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):39-46
The role of Inflasinusans in the treatment of acute rhinosinusitis. Russian Bulletin of Otorhinolaryngology. 2025;(4):64-71
Use of ozone therapy in the treatment of complications following pene­trating kera­toplasty for rosa­cea-associated kera­titis. Russian Annals of Ophthalmology. 2025;(4):66-72
Psychodermatological aspe­cts of psoriasis, current condition of problem. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):403-411
Abstract:

OBJECTIVE

To evaluate the efficacy of alpha-glutamyl-tryptophan in the treatment of chronic atrophic gastritis through clinical case examples from routine medical practice.

MATERIAL AND METHODS

Four clinical cases were selected to demonstrate the effectiveness of alpha-glutamyl-tryptophan as an anti-inflammatory agent and promoter of gastric mucosal repair in patients with chronic atrophic gastritis of varying etiologies (Helicobacter pylori-associated and autoimmune). Alpha-glutamyl-tryptophan was administered for 28 days. In cases of H. pylori-associated gastritis, it was used following standard eradication therapy, whereas in H. pylori-negative autoimmune gastritis, it was used as a first-line treatment.

RESULTS

Patients with gastric mucosal atrophy who received alpha-glutamyl-tryptophan exhibited clinical improvement (symptom resolution post-treatment), histological improvement (reduced inflammation and atrophy regression, indicated by increased gland density per mm² of gastric mucosa), and improved gastric function (elevation in pepsinogen I levels). The most challenging case involved H. pylori-associated atrophic gastritis in a patient with uncontrolled nonsteroidal anti-inflammatory drug use; nonetheless, alpha-glutamyl-tryptophan as part of a comprehensive treatment demonstrated regenerative and anti-inflammatory effects.

CONCLUSION

The presented clinical cases suggest that alpha-glutamyl-tryptophan (Regastim Gastro) contributes to the regression of atrophy, improvement of functional activity, and reduction of inflammation in the gastric mucosa. For chronic atrophic gastritis, particularly in autoimmune cases, repeated courses of treatment are recommended with intervals of at least two weeks.

Keywords:

gastritis
inflammation
atrophy
alpha-glutamyl-tryptophan
Helicobacter pylori

Authors:

Uspenskiy Yu.P.

Saint Petersburg State Pediatric Medical University;
Pavlov First Saint Petersburg State Medical University

Baryshnikova N.V.

Saint Petersburg State Pediatric Medical University;
Pavlov First Saint Petersburg State Medical University;
Institute of Experimental Medicine

Fominykh Yu.A.

Saint Petersburg State Pediatric Medical University

Shekhtman A.V.

Saint Elizabeth City Hospital

Received:

20.10.2024

Accepted:

25.10.2024

Close metadata

References:

  1. Tsukanov V, Vasyutin A, Tonkikh Yu, Peretyatko O. Diagnosis, prevalence and risk factors of atrophic gastritis. Vrach. 2018; 29(10):8-11. (In Russ.). https://doi.org/10.29296/25877305-2018-10-02
  2. Correa P. Helicobacter pylori and gastric carcinogenesis. American Journal of Surgical Pathology. 1995;19(Suppl 1):S37-S43. 
  3. Correa P. Gastric cancer: overview. Gastroenterology Clinics of North America. 2013;42(2):211-217.  https://doi.org/10.1016/j.gtc.2013.01.002
  4. Malfertheiner P, Megraud F, O’Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ. Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut. 2007;56(6):772-781.  https://doi.org/10.1136/gut.2006.101634
  5. Tryapitsyn AV, Malkov VA, Gasanov EM, Belyakov IA. Chronic gastritis and precancerous diseases of the stomach: Is there a chance of a correct diagnosis? Vestnik Severo-Zapadnogo gosudarstvennogo meditsinskogo universiteta im. I.I. Mechnikova. 2021; 13(1):85-102. (In Russ.). https://doi.org/10.17816/mechnikov60431
  6. International Agency for Research on Cancer. IARC (1994) Schistosomes, Liver Flukes and Helicobacter Pylori (IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 61). Lyon; IARC. Accessed March 21, 2024. https://www.iarc.who.int/world-cancer-report-content-overview
  7. Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, Gasbarrini A, Hunt RH, Leja M, O’Morain C, Rugge M, Suerbaum S, Tilg H, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study group. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;gutjnl-2022-327745. https://doi.org/10.1136/gutjnl-2022-327745
  8. Petlenko IS, Egorova TYu, Petlenko SV, Bezgodkov YuA, Vorontsova TN. Experimental study of the specific activity of L-Glutamyl- L-Tryptophan. Sovremennye problemy nauki i obrazovaniya. 2019;3. (In Russ.). Accessed October 27, 2024. https://science-education.ru/ru/article/view?id=28988
  9. Selina EN, Kudryavtseva TA, Rodionova OM, Kuznetsova NN, Krasnov AA, Petlenko SV, Apryatina VA. Therapeutic and preventive effect of alpha-glutamyl-tryptophan on gastric mucosal lesions caused by non-steroidal anti-inflammatory drugs. An experimental study. Russian Journal of Evidence-Based Gastroenterology. 2024;13(2):25-34. (In Russ.). https://doi.org/10.17116/dokgastro20241302125
  10. Petlenko SV, Golovacheva EG, Afanasieva OI. Opportunities for immunocorrection aiming for reduction of morbidity in the areas with adverse occupational and environmental conditions. Meditsinskaya immunologiya. 2020;22(6):1097-1110. (In Russ.). https://doi.org/10.15789/1563-0625-OFI-2055
  11. Baryshnikova NV, Fominykh YuA, Ivanov SV, Gnutov AA, Sousova YaV. Ispol’zovanie alfa-glutamil-triptofana dlya profilaktiki raka zheludka u patsientov s khronicheskim atroficheskim gastritom. Metodicheskie rekomendatsii. Utverzhdeny Komitetom po zdravookhraneniyu Sankt-Peterburga. SPb; 2022. (In Russ.). Accessed March 20, 2024. https://www.gastroscan.ru/literature/pdf/baryshnikova-alpha-glutamyl-triptophanum.pdf
  12. Baryshnikova NV, Uspensky YuP, Fominykh YuA, Kalinina EYu, Krylova YS, Krasnov AA, Petlenko SV, Apryatina VA. Repair stimulator alpha-glutamyl-tryptophan in the complex therapy of chronic atrophic gastritis: results of histological examination. Russian Journal of Archive of Pathology. 2023;85(3):54-63. (In Russ.). https://doi.org/10.17116/patol20238503154
  13. Baryshnikova NV, Uspenskiy YuP, Fominykh YuA, Petlenko SV, Zaplutanov VA, Apryatina VA, Krasnov AA. Endoscopic and morphometric analysis of the reduction of acute inflammatory process in the gastric mucosa after therapy with Regasthym Gastro. Terapevticheskij arkhiv. 2023;95(4):322-326. (In Russ.). https://doi.org/10.26442/00403660.2023.04.202147
  14. Ohashi H, Maruyama T, Higashi-Matsumoto H, Nomoto T, Nishimura S, Takeuchi Y. A novel binding assay for metabotropic glutamate receptors using [3H] L-quisqualic acid and recombinant receptors. Zeitschrift für Naturforschung C: Journal of Biosciences. 2002;57(3-4):348-355.  https://doi.org/10.1515/znc-2002-3-425
  15. Shevtsov MA, Smagina LV, Kudriavtceva TA, Petlenko SV, Voronkina IV. Glu-Trp-ONa or its acylated analogue (R-Glu-Trp-ONa) administration enhances the wound healing in the model of chronic skin wounds in rabbits. Drug Design, Development and Therapy. 2015;9:1717-1727. https://doi.org/10.2147/DDDT.S79665
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.